ARF Impedes NPM/B23 Shuttling in an Mdm2-Sensitive Tumor Suppressor Pathway
暂无分享,去创建一个
J. Weber | L. Maggi | Jason D. Weber | Leonard B. Maggi | Suzanne N. Brady | Yue Yu | S. Brady | Yue Yu | Leonard Maggi
[1] Charles J. Sherr,et al. Physical and Functional Interactions of the Arf Tumor Suppressor Protein with Nucleophosmin/B23 , 2004, Molecular and Cellular Biology.
[2] W. Franke,et al. DNA cloning and amino acid sequence determination of a major constituent protein of mammalian nucleoli , 2004, Chromosoma.
[3] M. Mann,et al. Proteomic characterization of the human centrosome by protein correlation profiling , 2003, Nature.
[4] David Hawke,et al. Tumor suppressor ARF degrades B23, a nucleolar protein involved in ribosome biogenesis and cell proliferation. , 2003, Molecular cell.
[5] Mei-Ling Kuo,et al. Nucleolar Arf tumor suppressor inhibits ribosomal RNA processing. , 2003, Molecular cell.
[6] K. Nagata,et al. The RNA binding activity of a ribosome biogenesis factor, nucleophosmin/B23, is modulated by phosphorylation with a cell cycle-dependent kinase and by association with its subtype. , 2002, Molecular biology of the cell.
[7] F. Zindy,et al. The Arf tumor suppressor gene promotes hyaloid vascular regression during mouse eye development , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[8] M. Mann,et al. Directed Proteomic Analysis of the Human Nucleolus , 2002, Current Biology.
[9] C. Korgaonkar,et al. ARF Function Does Not Require p53 Stabilization or Mdm2 Relocalization , 2002, Molecular and Cellular Biology.
[10] R. Kriwacki,et al. Defining the molecular basis of Arf and Hdm2 interactions. , 2001, Journal of molecular biology.
[11] D. Lane,et al. Different effects of p14ARF on the levels of ubiquitinated p53 and Mdm2 in vivo , 2001, Oncogene.
[12] H. F. Horn,et al. Specific Phosphorylation of Nucleophosmin on Thr199 by Cyclin- dependent Kinase 2-Cyclin E and Its Role in Centrosome Duplication* , 2001, The Journal of Biological Chemistry.
[13] G. Peters,et al. Stabilization of p53 by p14ARF without relocation of MDM2 to the nucleolus , 2001, Nature Cell Biology.
[14] R. Kriwacki,et al. Solution structure of the p53 regulatory domain of the p19Arf tumor suppressor protein. , 2001, Biochemistry.
[15] H. F. Horn,et al. Nucleophosmin/B23 Is a Target of CDK2/Cyclin E in Centrosome Duplication , 2000, Cell.
[16] M. Roussel,et al. p53-independent functions of the p19(ARF) tumor suppressor. , 2000, Genes & development.
[17] D. Lane,et al. An N-terminal p14ARF peptide blocks Mdm2-dependent ubiquitination in vitro and can activate p53 in vivo , 2000, Oncogene.
[18] M. Lindström,et al. Immunolocalization of human p14(ARF) to the granular component of the interphase nucleolus. , 2000, Experimental cell research.
[19] M. Kubbutat,et al. Contribution of two independent MDM2-binding domains in p14ARF to p53 stabilization , 2000, Current Biology.
[20] M. Roussel,et al. Cooperative Signals Governing ARF-Mdm2 Interaction and Nucleolar Localization of the Complex , 2000, Molecular and Cellular Biology.
[21] M. Kubbutat,et al. Identification of a cryptic nucleolar-localization signal in MDM2 , 2000, Nature Cell Biology.
[22] D. Beach,et al. p16INK4A and p19ARF act in overlapping pathways in cellular immortalization , 2000, Nature Cell Biology.
[23] J. D. Weber,et al. The ARF/p53 pathway. , 2000, Current opinion in genetics & development.
[24] M. Roussel,et al. Disruption of the ARF-Mdm2-p53 tumor suppressor pathway in Myc-induced lymphomagenesis. , 1999, Genes & development.
[25] A. Levine,et al. P19(ARF) stabilizes p53 by blocking nucleo-cytoplasmic shuttling of Mdm2. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[26] Charles J. Sherr,et al. Nucleolar Arf sequesters Mdm2 and activates p53 , 1999, Nature Cell Biology.
[27] D. H. Randle,et al. Tumor spectrum in ARF-deficient mice. , 1999, Cancer research.
[28] B. Yung,et al. Down-regulation of nucleophosmin/B23 mRNA delays the entry of cells into mitosis. , 1999, Biochemical and biophysical research communications.
[29] M. Roussel,et al. Induction of ARF tumor suppressor gene expression and cell cycle arrest by transcription factor DMP1. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[30] A. Levine,et al. Nucleocytoplasmic shuttling of oncoprotein Hdm2 is required for Hdm2-mediated degradation of p53. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[31] G. Wahl,et al. A leucine‐rich nuclear export signal in the p53 tetramerization domain: regulation of subcellular localization and p53 activity by NES masking , 1999, The EMBO journal.
[32] M. Bornens,et al. The nucleolar phosphoprotein B23 redistributes in part to the spindle poles during mitosis. , 1999, Journal of cell science.
[33] R. Honda,et al. Association of p19ARF with Mdm2 inhibits ubiquitin ligase activity of Mdm2 for tumor suppressor p53 , 1999, The EMBO journal.
[34] Karen H. Vousden,et al. p14ARF links the tumour suppressors RB and p53 , 1998, Nature.
[35] J L Cleveland,et al. Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization. , 1998, Genes & development.
[36] S. Lowe,et al. E1A signaling to p53 involves the p19(ARF) tumor suppressor. , 1998, Genes & development.
[37] Ken Chen,et al. The Ink4a Tumor Suppressor Gene Product, p19Arf, Interacts with MDM2 and Neutralizes MDM2's Inhibition of p53 , 1998, Cell.
[38] Richard A. Ashmun,et al. Tumor Suppression at the Mouse INK4a Locus Mediated by the Alternative Reading Frame Product p19 ARF , 1997, Cell.
[39] T. Taniguchi,et al. Identification and characterization of nucleophosmin/B23/numatrin which binds the anti-oncogenic transcription factor IRF-1 and manifests oncogenic activity , 1997, Oncogene.
[40] G. Dreyfuss,et al. A Novel Receptor-Mediated Nuclear Protein Import Pathway , 1996, Cell.
[41] F. Zindy,et al. Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest , 1995, Cell.
[42] B. Yung,et al. Cell cycle phase-dependent changes of localization and oligomerization states of nucleophosmin / B23. , 1995, Biochemical and biophysical research communications.
[43] M. Roussel,et al. Rescue of defective mitogenic signaling by D-type cyclins. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[44] R. Weinberg,et al. Tumor spectrum analysis in p53-mutant mice , 1994, Current Biology.
[45] G. Hannon,et al. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4 , 1993, Nature.
[46] P. Chan,et al. Formation of nucleophosmin/B23 oligomers requires both the amino- and the carboxyl-terminal domains of the protein. , 1991, European journal of biochemistry.
[47] C. Lehner,et al. Major nucleolar proteins shuttle between nucleus and cytoplasm , 1989, Cell.
[48] N. Feuerstein,et al. Identification of numatrin, the nuclear matrix protein associated with induction of mitogenesis, as the nucleolar protein B23. Implication for the role of the nucleolus in early transduction of mitogenic signals. , 1988, The Journal of biological chemistry.